Apart from the significance of the genetically conditioned decreased eNOS release/availability, obesity and inflammation also lead to reduced eNOS bioavailability and consequently to cardiovascular diseases [26, 38, 39]. This evidence concerns the gene NOS3 and obesity due to melanocortin 4 receptor deficiency.